首页> 外国专利> Injectable Pharmaceutical composition comprising ibuprofen, an aqueous solution and a solubilizing Agent is selected from Sodium Phosphates, carbonates of potassium, sodium, potassium and / or combinations of them.

Injectable Pharmaceutical composition comprising ibuprofen, an aqueous solution and a solubilizing Agent is selected from Sodium Phosphates, carbonates of potassium, sodium, potassium and / or combinations of them.

机译:包含布洛芬,水溶液和增溶剂的可注射药物组合物选自磷酸钠,钾,钠,钾和/或碳的碳酸盐或它们的组合。

摘要

The present invention provides a pharmaceutical composition comprising an aqueous solution of an ibuprofen solubilizing agent and ibuprofen, the ibuprofen solubilizing agent being in an effective amount such that the ibuprofen in the solution remains soluble at concentrations from lOOmg/mL to 5mg/mL without undergoing a phase transition. The invention further provides a method of treating a condition chosen from pain, inflammation, fever, and/or patent ductus arteriosis, comprising administering to a patient in need thereof an effective amount of an aqueous solution a ibuprofen solubilizing agent and ibuprofen, the ibuprofen solubilizing agent being in an effective amount such that the ibuprofen in the solution remains soluble at concentrations from lOOmg/mL to 5mg/mL without undergoing a phase transition, as well as a method for manufacturing the composition.
机译:本发明提供了一种药物组合物,其包含布洛芬增溶剂和布洛芬的水溶液,所述布洛芬增溶剂的有效量使得所述溶液中的布洛芬在100mg / mL至5mg / mL的浓度下保持可溶而不经历相变。本发明进一步提供了一种治疗选自疼痛,炎症,发烧和/或导管未闭的疾病的方法,该方法包括向有需要的患者施用有效量的水溶液布洛芬增溶剂和布洛芬,所述布洛芬增溶剂有效量的药物及其制备方法,以使溶液中的布洛芬在100mg / mL至5mg / mL的浓度下保持可溶而不发生相变。

著录项

  • 公开/公告号CL2014002414A1

    专利类型

  • 公开/公告日2015-04-06

    原文格式PDF

  • 申请/专利权人 CUMBERLAND PHARMACEUTICALS INC.;

    申请/专利号CL20140002414

  • 发明设计人 VILA ANDREW;PAVLIL LEO;

    申请日2014-09-12

  • 分类号A01N37/10;A61K31/19;

  • 国家 CL

  • 入库时间 2022-08-21 15:15:54

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号